Goldman Sachs’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$328K Sell
40,339
-47,659
-54% -$387K ﹤0.01% 4476
2025
Q1
$620K Buy
87,998
+12,647
+17% +$89K ﹤0.01% 4136
2024
Q4
$560K Buy
75,351
+16,437
+28% +$122K ﹤0.01% 4242
2024
Q3
$290K Buy
58,914
+20,038
+52% +$98.8K ﹤0.01% 4353
2024
Q2
$199K Sell
38,876
-48,825
-56% -$250K ﹤0.01% 4372
2024
Q1
$466K Buy
87,701
+54,106
+161% +$287K ﹤0.01% 4024
2023
Q4
$208K Buy
33,595
+22,558
+204% +$140K ﹤0.01% 4313
2023
Q3
$83.3K Sell
11,037
-34,199
-76% -$258K ﹤0.01% 4420
2023
Q2
$437K Sell
45,236
-29,564
-40% -$286K ﹤0.01% 4043
2023
Q1
$282K Buy
74,800
+6,422
+9% +$24.2K ﹤0.01% 4373
2022
Q4
$443K Sell
68,378
-13,539
-17% -$87.7K ﹤0.01% 4160
2022
Q3
$728K Buy
81,917
+3,139
+4% +$27.9K ﹤0.01% 4016
2022
Q2
$785K Sell
78,778
-9,288
-11% -$92.6K ﹤0.01% 4110
2022
Q1
$1.02M Sell
88,066
-9,709
-10% -$112K ﹤0.01% 4082
2021
Q4
$1.09M Buy
97,775
+61,148
+167% +$679K ﹤0.01% 3964
2021
Q3
$338K Sell
36,627
-56,102
-61% -$518K ﹤0.01% 4594
2021
Q2
$1.04M Sell
92,729
-51,706
-36% -$582K ﹤0.01% 3982
2021
Q1
$1.53M Sell
144,435
-103,150
-42% -$1.09M ﹤0.01% 3604
2020
Q4
$2.69M Buy
247,585
+39,528
+19% +$429K ﹤0.01% 2884
2020
Q3
$2.02M Buy
208,057
+8,219
+4% +$79.9K ﹤0.01% 2896
2020
Q2
$1.59M Buy
199,838
+80,705
+68% +$642K ﹤0.01% 2960
2020
Q1
$1.04M Buy
119,133
+3,794
+3% +$33K ﹤0.01% 3096
2019
Q4
$1.3M Buy
115,339
+48,864
+74% +$552K ﹤0.01% 3183
2019
Q3
$722K Buy
66,475
+29,584
+80% +$321K ﹤0.01% 3425
2019
Q2
$346K Sell
36,891
-11,025
-23% -$103K ﹤0.01% 3669
2019
Q1
$588K Sell
47,916
-14,438
-23% -$177K ﹤0.01% 3493
2018
Q4
$738K Buy
62,354
+4,889
+9% +$57.9K ﹤0.01% 3268
2018
Q3
$827K Buy
57,465
+26,982
+89% +$388K ﹤0.01% 3269
2018
Q2
$454K Sell
30,483
-23,272
-43% -$347K ﹤0.01% 3565
2018
Q1
$702K Sell
53,755
-3,104
-5% -$40.5K ﹤0.01% 3339
2017
Q4
$716K Sell
56,859
-361
-0.6% -$4.55K ﹤0.01% 3290
2017
Q3
$741K Buy
57,220
+4,561
+9% +$59.1K ﹤0.01% 3355
2017
Q2
$782K Buy
52,659
+4,594
+10% +$68.2K ﹤0.01% 3279
2017
Q1
$577K Buy
48,065
+2,311
+5% +$27.7K ﹤0.01% 3420
2016
Q4
$631K Buy
45,754
+4,717
+11% +$65.1K ﹤0.01% 3327
2016
Q3
$550K Buy
41,037
+21,358
+109% +$286K ﹤0.01% 3384
2016
Q2
$212K Buy
19,679
+407
+2% +$4.39K ﹤0.01% 3832
2016
Q1
$202K Sell
19,272
-1,352
-7% -$14.2K ﹤0.01% 3763
2015
Q4
$244K Sell
20,624
-2,093
-9% -$24.8K ﹤0.01% 3625
2015
Q3
$265K Buy
22,717
+7,940
+54% +$92.6K ﹤0.01% 3673
2015
Q2
$213K Sell
14,777
-6,388
-30% -$92.1K ﹤0.01% 3967
2015
Q1
$295K Sell
21,165
-4,258
-17% -$59.3K ﹤0.01% 3650
2014
Q4
$351K Sell
25,423
-3,050
-11% -$42.1K ﹤0.01% 3590
2014
Q3
$349K Buy
28,473
+1,264
+5% +$15.5K ﹤0.01% 3553
2014
Q2
$340K Sell
27,209
-3,900
-13% -$48.7K ﹤0.01% 3590
2014
Q1
$347K Sell
31,109
-33,953
-52% -$379K ﹤0.01% 3595
2013
Q4
$789K Buy
65,062
+11,846
+22% +$144K ﹤0.01% 3191
2013
Q3
$649K Sell
53,216
-3,381
-6% -$41.2K ﹤0.01% 3183
2013
Q2
$748K Buy
+56,597
New +$748K ﹤0.01% 2945